Envoy Medical Inc
COCH0.733USD
+0.033+4.67%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
17.45MMarket Cap
LossP/E TTM
More Details of Envoy Medical Inc Company
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Envoy Medical Inc Info
Ticker SymbolCOCH
Company nameEnvoy Medical Inc
IPO dateMar 02, 2021
CEOLucas (Brent T)
Number of employees42
Security typeOrdinary Share
Fiscal year-endMar 02
Address4875 White Bear Parkway
CityWHITE BEAR LAKE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55110
Phone16513618000
Websitehttps://www.envoymedical.com/
Ticker SymbolCOCH
IPO dateMar 02, 2021
CEOLucas (Brent T)
Company Executives of Envoy Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Nov 25
Updated: Tue, Nov 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.18%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.82%
Other
59.48%
Shareholders
Shareholders
Proportion
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.18%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.82%
Other
59.48%
Shareholder Types
Shareholders
Proportion
Individual Investor
37.08%
Investment Advisor
3.33%
Private Equity
1.93%
Investment Advisor/Hedge Fund
1.27%
Hedge Fund
1.23%
Research Firm
0.06%
Other
55.09%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
47
2.25M
9.80%
+81.14K
2025Q3
59
2.17M
17.45%
-288.93K
2025Q2
64
2.46M
24.39%
+3.06K
2025Q1
70
2.46M
24.73%
-2.82M
2024Q4
143
2.12M
158.30%
+927.59K
2024Q3
151
1.20M
185.14%
-129.06K
2024Q2
157
1.33M
194.46%
+97.08K
2024Q1
156
1.23M
199.37%
-37.85M
2023Q4
150
1.71M
201.29%
-1.36M
2023Q3
149
3.06M
201.92%
-985.94K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Taylor (Glen A)
10.29M
46.98%
--
--
Apr 10, 2025
Atlas Merchant Capital LLC
555.53K
2.54%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
394.96K
1.8%
--
--
Jun 30, 2025
Weiss Asset Management
368.14K
1.68%
-19.82K
-5.11%
Jun 30, 2025
Lucas (Brent T)
209.46K
0.96%
+7.74K
+3.84%
May 30, 2025
Focus Partners Wealth, LLC
212.66K
0.97%
--
--
Jun 30, 2025
DSG Capital Advisors, LLC
163.64K
0.75%
--
--
Jun 30, 2025
Arcus Capital Partners, LLC
187.57K
0.86%
--
--
Jun 30, 2025
Meteora Capital LLC
108.51K
0.5%
--
--
Apr 10, 2025
Kantor (Susan J.)
77.89K
0.36%
--
--
Apr 10, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Envoy Medical Inc?
The top five shareholders of Envoy Medical Inc are:
Taylor (Glen A) holds 10.29M shares, accounting for 46.98% of the total shares.
Atlas Merchant Capital LLC holds 555.53K shares, accounting for 2.54% of the total shares.
The Vanguard Group, Inc. holds 394.96K shares, accounting for 1.80% of the total shares.
Weiss Asset Management holds 368.14K shares, accounting for 1.68% of the total shares.
Lucas (Brent T) holds 209.46K shares, accounting for 0.96% of the total shares.
Taylor (Glen A) holds 10.29M shares, accounting for 46.98% of the total shares.
Atlas Merchant Capital LLC holds 555.53K shares, accounting for 2.54% of the total shares.
The Vanguard Group, Inc. holds 394.96K shares, accounting for 1.80% of the total shares.
Weiss Asset Management holds 368.14K shares, accounting for 1.68% of the total shares.
Lucas (Brent T) holds 209.46K shares, accounting for 0.96% of the total shares.
What are the top three shareholder types of Envoy Medical Inc?
The top three shareholder types of Envoy Medical Inc are:
Taylor (Glen A)
Atlas Merchant Capital LLC
The Vanguard Group, Inc.
Taylor (Glen A)
Atlas Merchant Capital LLC
The Vanguard Group, Inc.
How many institutions hold shares of Envoy Medical Inc (COCH)?
As of 2025Q4, 47 institutions hold shares of Envoy Medical Inc, with a combined market value of approximately 2.25M, accounting for 9.80% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -7.65%.
What is the biggest source of revenue for Envoy Medical Inc?
In --, the -- business generated the highest revenue for Envoy Medical Inc, amounting to -- and accounting for --% of total revenue.
